Siew C Ng
Overview
Explore the profile of Siew C Ng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
297
Citations
18505
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang W, Zhu W, Lin Y, Chan F, Xu Z, Ng S
Gut Microbes
. 2025 Feb;
17(1):2467193.
PMID: 39976263
Next-generation live biotherapeutics are promising to aid the treatment of obesity and metabolic diseases. Here, we reported a novel anti-obesity probiotic candidate, , that was depleted in stool samples of...
2.
Afzali A, Regueiro M, Yarur A, Zabana Y, Ng S, Menon S, et al.
United European Gastroenterol J
. 2025 Feb;
PMID: 39891572
Background: Etrasimod is an oral, once-daily (q.d.), selective sphingosine 1-phosphate (S1P) receptor modulator for the treatment of moderately to severely active ulcerative colitis (UC). Unlike the S1P receptor modulator ozanimod,...
3.
Lau R, Su Q, Ng S
Gut Microbes
. 2025 Jan;
17(1):2457495.
PMID: 39854158
Post-acute coronavirus disease 2019 syndrome (PACS), following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (COVID-19), is typically characterized by long-term debilitating symptoms affecting multiple organs...
4.
Dai M, Xiao X, Guo C, Lui R, Yip H, Chu S, et al.
United European Gastroenterol J
. 2024 Dec;
PMID: 39707920
Introduction: Long-term data on metachronous advanced adenoma (AA) recurrence after endoscopic submucosal dissection (ESD) remain scarce, leading to a lack of a standardized surveillance strategy. This study aims to evaluate...
5.
Porcari S, Mullish B, Asnicar F, Ng S, Zhao L, Hansen R, et al.
Lancet Gastroenterol Hepatol
. 2024 Dec;
10(2):154-167.
PMID: 39647502
There is growing interest in the potential exploitation of the gut microbiome as a diagnostic tool in medicine, but evidence supporting its clinical usefulness is scarce. An increasing number of...
6.
Su Q, Wong O, Lu W, Wan Y, Zhang L, Xu W, et al.
Nat Microbiol
. 2024 Dec;
10(2):600.
PMID: 39633091
No abstract available.
7.
Chevarin C, Xu Z, Martin L, Robin F, Beyrouthy R, Colombel J, et al.
Gut Microbes
. 2024 Nov;
16(1):2431645.
PMID: 39587720
Association between ileal colonization by Adherent-Invasive (AIEC) and Crohn's disease (CD) has been widely described in high-incidence Western countries but remains unexplored in Asian countries with a fast increase in...
8.
Short-chain fatty acids in viral infection: the underlying mechanisms, opportunities, and challenges
Tsui Y, Wu X, Zhang X, Peng Y, Mok C, Chan F, et al.
Trends Microbiol
. 2024 Nov;
33(3):302-320.
PMID: 39505671
Viral infections can cause cellular pathway derangements, cell death, and immunopathological responses, leading to host inflammation. Short-chain fatty acids (SCFAs), produced by the microbiota, have emerged as a potential therapeutic...
9.
Xu Z, Yeoh Y, Tun H, Fei N, Zhang J, Morrison M, et al.
Microbiol Spectr
. 2024 Oct;
:e0151624.
PMID: 39475247
The reproducibility in microbiome studies is limited due to the lack of one gold-standard operating procedure. The aim of this study was to examine the impact of protocol variations on...
10.
Wan Y, Wong O, Tun H, Su Q, Xu Z, Tang W, et al.
Gut Microbes
. 2024 Oct;
16(1):2418984.
PMID: 39468837
Accumulating evidence suggests that gut microbiota alterations influence brain function and could serve as diagnostic biomarkers and therapeutic targets. The potential of using fecal microbiota signatures to aid autism spectrum...